Outcome of Board meeting along with financial results is hereby submitted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 3.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HOCL's Board approved unaudited limited-reviewed financial results for Q3 FY26 and nine months ended Dec 31, 2025. Standalone revenue from operations fell to Rs. 12,626.75 lakhs from Rs. 16,516.14 lakhs a year earlier (down ~24%). Standalone net loss narrowed sharply to Rs. 397.01 lakhs in Q3 from Rs. 7,876.69 lakhs in Q3 FY25, helped by a large one-time exceptional charge in the prior year. For nine months, net loss came in at Rs. 1,813.71 lakhs versus Rs. 12,813.37 lakhs. The auditors (Balan & Co) issued an unmodified opinion on both standalone and consolidated results, but flagged emphasis-of-matter notes on the going concern basis, the struggling subsidiary Hindustan Fluorocarbons, and non-compliance with SEBI rules on independent directors. The company also disclosed a Government of India waiver of its long-standing loan of Rs. 43,586.46 lakhs and preference shares of Rs. 27,000 lakhs.
Sharply lower revenue is a concern for shareholders, but the narrower losses, GOI debt/interest waiver, and clean auditor opinion (with only emphasis-of-matter notes) are positives. Near-term stock reaction may be muted; the structural turnaround hinges on the Government-approved restructuring plan and land sales.